This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: University of South Florida, University of Michigan, Transform Pharmaceuticals, Inc.. Active years: 2005-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Providence, RI (US) (2011)
- Temple Terrace, FL (US) (2005 - 2020)
Company Filing History:



Years Active: 2005-2020
Title: Brian Moulton: Pharmaceutical Co-Crystal Inventions
Introduction
Brian Moulton is an inventor associated with Temple Terrace, Florida. His work includes pharmaceutical solid phases and co-crystal compositions, and he is credited with 3 patents. His professional affiliations include the University of South Florida and the University of Michigan.
Latest Patents
Moulton’s listed patents address ways to develop and characterize pharmaceutical materials.
“Multiple-component solid phases containing at least one active pharmaceutical ingredient” concerns methods for identifying complementary chemical functionalities that can form a desired supramolecular synthon. It also describes binary phase compositions containing one or more pharmaceutical entities and methods for producing them.
“Pharmaceutical co-crystal compositions” describes compositions containing a co-crystal formed from an active pharmaceutical ingredient (API) and a co-crystal former. The invention identifies functional groups that may enable these components to co-crystallize from a solution under suitable crystallization conditions.
Career Highlights
Moulton’s listed institutional affiliations are the University of South Florida and the University of Michigan. His patent work focuses on pharmaceutical crystallization and the design of solid-state compositions.
Collaborations
His listed collaborators include Michael John Zaworotko and Nair Rodriguez-Hornedo. Their shared work is reflected in the patent subject matter concerning pharmaceutical co-crystals and multicomponent solid phases.
Conclusion
Brian Moulton’s patent portfolio highlights approaches to forming pharmaceutical co-crystals and other multicomponent solid phases, connecting his research affiliations with innovations in pharmaceutical materials.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile